Gland Pharma (NSE:GLAND) Other Operating Expense : ₹25,031 Mil (TTM As of Mar. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Gland Pharma Other Operating Expense?

Gland Pharma's Other Operating Expense for the three months ended in Mar. 2024 was ₹6,720 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₹25,031 Mil.

Gland Pharma's quarterly Other Operating Expense increased from Sep. 2023 (₹6,091 Mil) to Dec. 2023 (₹6,949 Mil) but then declined from Dec. 2023 (₹6,949 Mil) to Mar. 2024 (₹6,720 Mil).

Gland Pharma's annual Other Operating Expense increased from Mar. 2022 (₹7,608 Mil) to Mar. 2023 (₹9,452 Mil) and increased from Mar. 2023 (₹9,452 Mil) to Mar. 2024 (₹25,031 Mil).

Gland Pharma Other Operating Expense Historical Data

The historical data trend for Gland Pharma's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gland Pharma Other Operating Expense Chart

Gland Pharma Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Other Operating Expense

Get a 7-Day Free Trial

5,533.59

6,428.79

7,607.55

9,452.06

25,031.27

Gland Pharma Quarterly Data
	Mar19	Jun19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Other Operating Expense	Get a 7-Day Free Trial															2,892.94	5,271.51	6,090.81	6,948.68	6,720.27

Gland Pharma Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹25,031 Mil.

Gland Pharma Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Gland Pharma's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Gland Pharma (NSE:GLAND) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gland Pharma Ltd (NSE:GLAND) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

543245:India

Address

Plot No. 11 and 84, TSIIC Phase: IV, Pashamylaram (V), Patancheru (M), Sangareddy District, Hyderabad, TG, IND, 502307

Website

https://www.glandpharma.com

Gland Pharma Ltd is engaged in the development, manufacturing, and marketing of complex injectables. The company's key molecules include Heparin Sodium Injection, Enoxaparin Sodium Injection, Rocuronium Bromide Injection, Daptomycin Injection, among others. Further, the group is involved in vast range of therapeutic categories that include Anti-Infectives, Anesthetics, Anti-Coagulants and their Antidotes, Anti-Malarial, Cardiology and more - to Hormones and related Drugs, Fertility Supplements and Gnrh Agonists and Antagonists. Geographically, it derives a majority of revenue from the USA.

Gland Pharma (NSE:GLAND) Headlines

No Headlines